www.onkologiecs.cz 47 / Onkologie. 2024;18(1):43-47 / ONKOLOGIE HLAVNÍ TÉMA Chirurgická léčba karcinomu endometria došlo odklonu od otevřené operativy ve prospěch minimálně invazivního přístupu, má stále své výsadní místo v léčbě pokročilých stadií při cytoredukčních, paliativních výkonech a ve specifických klinických scénářích. Nadále se rozvíjí robotická chirurgie včetně single site operací, které pokračují v trendu minimalizace invazivnosti výkonu a potažmo zkracování rekonvalescence. Bez povšimnutí nelze také nechat nový stagingový systém FIGO 2023, které po vzoru konsenzu ESGO/ ESTRO/ESP nově integroval molekulární klasifikaci a uvidíme, jakého se mu dostane přijetí. Do budoucna lze s napětím očekávat výsledky navazujících klinických studií, které pomohou v dalším zlepšování adjuvantní a fertility sparing léčby založené na molekulárních faktorech u karcinomu endometria. LITERATURA 1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer J Clin. 2021;71:209-249. 2. Potischman N, Swanson CA, Siiteri P, et al. Reversal of Relation Between Body Mass and Endogenous Estrogen Concentrations With Menopausal Status. JNCI: J Natl Cancer Inst. 1996;88:756-758. 3. Dušek L, Jan M, Miroslav K, et al. Epidemiologie zhoubných nádorů v České republice [online]. Epidemiologie zhoubných nádorů v České republice [online] Masarykova univerzita, [2005], [cit 2023-12-02]. Available from: www: http://www. svod.cz Verze 70 [2007]. 4. Seebacher V, Schmid M, Polterauer S, et al. The presence of postmenopausal bleeding as prognostic parameter in patients with endometrial cancer: a retrospective multi-center study. BMC Cancer. 2009;9:460. 5. Frias-Gomez J, Benavente Y, Ponce J, et al. Sensitivity of cervico-vaginal cytology in endometrial carcinoma: A systematic review and meta-analysis. Cancer Cytopathol. 2020; 128:792-802. 6. Haddad S, Ghadimi K, Abrishamkar R, et al. Comparing laparoscopy and laparotomy procedures in the radical hysterectomy surgery for endometrial cancer: a basic review. Am J Transl Res. 2020;13:2456-2461. 7. Sirák I, Špaček. J, Petera J. Standardní léčebný postup – protokol pro léčbu karcinomu těla dělohy. Standardní léčebný postup – Protokol pro léčbu karcinomu těla dělohy; 2023. Available from: www: https://www.fnhk.cz/fs3943/protokol-pro-lecbu-karcinomu-tela-delohy.pdf. 8. Walker JL, Piedmonte MR, Spirtos NM, et al. Recurrence and Survival After Random Assignment to Laparoscopy Versus Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group LAP2 Study. J Clin Oncol. 2012;30:695-700. 9. Janda M, Gebski V, Davies LC, et al. Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer: A Randomized Clinical Trial. JAMA. 2017;317:1224-1233. 10. Berek JS, Matias-Guiu X, Creutzberg C, et al. FIGO staging of endometrial cancer: 2023. Int J Gynecol Obstet. 2023;162:383-394. 11. Concin N, Matias-Guiu X, Vergote I, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021;31:12-39. 12. McCluggage WG, Bosse T, Gilks CB, et al. FIGO 2023 endometrial cancer staging: too much, too soon? Int J Gynecol Cancer. 2023;ijgc–2023–004981. 13. Cusimano MC, Simpson AN, Dossa F, et al. Laparoscopic and robotic hysterectomy in endometrial cancer patients with obesity: a systematic review and meta-analysis of conversions and complications. Am J Obstet Gynecol. 2019;221:410-428.e19. 14. Ørtoft G, Lausten-Thomsen L, Høgdall C, et al. Lymph- -vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study. J Gynecol Oncol. 2019;30:e84. 15. Bosse T, Peters EEM, Creutzberg CL, et al. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – A pooled analysis of PORTEC 1 and 2 trials. Eur J Cancer. 2015;51:1742-1750. 16. Horeweg N, Nout RA, Jürgenliemk-Schulz IM, et al. Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer. J Clin Oncol. 2023;41:4369-4380. 17. Mouraz M, Ferreira C, Gonçalves S, et al. Laparoscopic Approach in Surgical Staging of Endometrial Cancer. Rev Bras Ginecol e Obstet RBGO – Gynecol Obstet . 2019;41:306-311. 18. Uccella S, Bonzini M, Malzoni M, et al. The effect of a uterine manipulator on the recurrence and mortality of endometrial cancer: a multi-centric study by the Italian Society of Gynecological Endoscopy. Am J Obstet Gynecol. 2017;216:592.e1-592.e11. 19. Ito H, Moritake T, Isaka K. Does the use of a uterine manipulator in robotic surgery for early-stage endometrial cancer affect oncological outcomes? Int J Med Robot Comput Assist Surg. 2022;18 e2443. 20. Padilla-Iserte P, Lago V, Tauste C, et al. Impact of uterine manipulator on oncological outcome in endometrial cancer surgery. Am J Obstet Gynecol. 2021;224:65.e1-65.e11. 21. Mourits MJ, Bijen CB, Arts HJ, et al. Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trial. Lancet Oncol. 2010;11:763-771. 22. Practice Bulletin No. 149. Obstet Gynecol. 2015;125:1006-1026. 23. Adelman MR, Bardsley TR, Sharp HT. Urinary Tract Injuries in Laparoscopic Hysterectomy: A Systematic Review. J Minim Invasive Gynecol. 2014;21:558-566. 24. Llarena NC, Shah AB, Milad MP. Bowel Injury in Gynecologic Laparoscopy. Obstet Gynecol. 2015;125:1407-1417. 25. Hur H-C, Donnellan N, Mansuria S, et al. Vaginal Cuff Dehiscence After Different Modes of Hysterectomy. Obstet Gynecol. 2011;118:794-801. 26. Wright JD, Burke WM, Wilde ET, et al. Comparative Effectiveness of Robotic Versus Laparoscopic Hysterectomy for Endometrial Cancer. J Clin Oncol. 2012;30:783-791. 27. Ind T, Laios A, Hacking M, et al. A comparison of operative outcomes between standard and robotic laparoscopic surgery for endometrial cancer: A systematic review and meta-analysis. Int J Med Robot Comput Assist Surg. 2017;13:e1851. 28. Tandogdu Z, Vale L, Fraser C, et al. A Systematic Review of Economic Evaluations of the Use of Robotic Assisted Laparoscopy in Surgery Compared with Open or Laparoscopic Surgery. Appl Heal Econ Heal Polic. 2015;13:457-467. 29. Iavazzo C, Gkegkes ID. Cost-benefit analysis of robotic surgery in gynaecological oncology. Best Pr Res Clin Obstet Gynaecol. 2017;45:7-18. 30. Lundin ES, Carlsson P, Wodlin NB, et al. Cost-effectiveness of robotic hysterectomy versus abdominal hysterectomy in early endometrial cancer. Int J Gynecol Cancer. 2020;30: 1719-1725. 31. Corrado G, Mereu L, Bogliolo S, et al. Robotic single site staging in endometrial cancer: A multi-institution study. Eur J Surg Oncol (EJSO). 2016;42:1506-1511. 32. Horowitz NS, Powell MA, Drescher CW, et al. Adequate staging for uterine cancer can be performed through Pfannenstiel incisions. Gynecol Oncol. 20003;88:404-410. 33. Praiss AM, Huang Y, Clair CMSt, et al. Long-term outcomes of vaginal hysterectomy for endometrial cancer. Gynecol Oncol. 2022;164:105-112. 34. Schubert M, Mettler L, Tolani AD, et al. Fertility Preservation in Endometrial Cancer – Treatment and Molecular Aspects. Medicina. 2023;59:221. 35. Gallo A, Catena U, Saccone G, et al. Conservative Surgery in Endometrial Cancer. J Clin Med. 2021;11:183. 36. Won S, Kim MK, Seong SJ. Fertility-sparing treatment in women with endometrial cancer. Korean J Fertil Steril. 2020;47:237-244. 37. Crosbie EJ, Kitson SJ, McAlpine JN, et al. Endometrial cancer. Lancet. 2022;399:1412-1428. 38. Gunderson CC, Fader AN, Carson KA, et al. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol. 2011;125:477-82. 39. Barlin JN, Puri I, Bristow RE. Cytoreductive surgery for advanced or recurrent endometrial cancer: A meta-analysis. Gynecol Oncol. 2010;118:14-18.
RkJQdWJsaXNoZXIy NDA4Mjc=